Controversies in the Diagnosis and Management of NAFLD and NASH. - Wikidata - wikimedia - TriplyDB

Controversies in the Diagnosis and Management of NAFLD and NASH.

Controversies in the Diagnosis and Management of NAFLD and NASH.

http://www.wikidata.org/entity/Q30412296

about

Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.Chardonnay Grape Seed Flour Ameliorates Hepatic Steatosis and Insulin Resistance via Altered Hepatic Gene Expression for Oxidative Stress, Inflammation, and Lipid and Ceramide Synthesis in Diet-Induced Obese Mice Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis.Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study.In vivo bioluminescence imaging reveals copper deficiency in a murine model of nonalcoholic fatty liver disease.Chemokine ligand 2 and paraoxonase-1 in non-alcoholic fatty liver disease: The search for alternative causative factors.

P2860

Q26992163-CF616F22-0C39-4B76-A923-906E4BAF390A Q28079445-A6E5AACD-B1AF-4864-9B85-2E2F1409A553 Q30368624-6F51D460-BB43-4C6D-AFB0-E61388CF1183 Q34647400-5DCD6BFD-C835-4AE5-84F3-C620B2B06937 Q36224836-A4E74B54-BF73-4C13-AC99-9B712BBBD8C8 Q37037308-E8FDBAC4-CCCA-4125-A25F-DD3A60083BB0 Q37384502-2A1A0255-A4F4-48DF-9A50-89062E8F778B Q37514940-44C5910B-74EF-4487-8E03-27112BBBFE75 Q38381079-0CB80F25-22A1-4440-8D77-40ADACCBA10F

P2860

Controversies in the Diagnosis and Management of NAFLD and NASH.

http://www.wikidata.org/entity/Q30412296

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Controversies in the Diagnosis and Management of NAFLD and NASH.

@ast

Controversies in the Diagnosis and Management of NAFLD and NASH.

@en

type

label

Controversies in the Diagnosis and Management of NAFLD and NASH.

@ast

Controversies in the Diagnosis and Management of NAFLD and NASH.

@en

prefLabel

Controversies in the Diagnosis and Management of NAFLD and NASH.

@ast

Controversies in the Diagnosis and Management of NAFLD and NASH.

@en

P1433

Q30412296-09327E56-FCB8-41B0-A6F4-67AAF7201B2C

P1476

Q30412296-5B9EC0E2-2819-42F5-8A73-8E3597C58783

P2093

Q30412296-092949CD-AFC3-4F1B-844F-7C186D12EA7F

Q30412296-302891E4-6190-418A-A208-8224150C5299

Q30412296-45FBC220-ADD2-46D0-A066-72D74FDD3DDB

Q30412296-47C5C823-6349-446C-92A2-BAC0BFC9F316

Q30412296-763F0A96-0CD9-4626-8BD7-8F12E1E5D601

Q30412296-A9FA1B9A-1E49-4B0D-81FE-3910B6BC6CC5

Q30412296-DDBD736F-60E5-4E1B-BFDD-D63CCFCB9826

P2860

Q30412296-04761333-68A9-463D-981A-96E1EBE05CA5

Q30412296-04B1158B-4AB1-4862-9F1E-2B86F66AF14C

Q30412296-05C9873B-0D12-40E5-B656-ECA763FE6645

Q30412296-0ADD0CE8-8A1E-4975-A423-F949CEA46706

Q30412296-0F6C30FE-D40A-4989-86C3-8190C7607BC2

Q30412296-103D6ECC-0DE0-43BF-98E5-744A6613F631

Q30412296-12BFC844-FFB9-49E1-9533-4E209CF0DD9C

Q30412296-16D0B83C-5EB2-4E50-BFEC-302F0BDDA08A

Q30412296-197CCA24-FE77-4774-9E51-45BDE2E48904

Q30412296-1CBA5C73-BACF-44FE-8C8E-6BE1F3B84509

P304

Q30412296-393A0193-7AA8-4323-B033-071387D42B31

P31

Q30412296-93720F84-4B02-4E4F-8B9E-FCC42B23BD51

P433

Q30412296-0537E40E-6C2F-4084-9355-E73D288092D5

P478

Q30412296-C46A53BF-FA04-4272-B19F-AE48133EADC7

P577

Q30412296-1E26A9BF-2CC9-4A33-ACB8-6E676552E6F2

P698

Q30412296-53FEB203-36BB-4484-B9EE-FEDFFAAAE14A

P932

Q30412296-97E61EC5-30A6-4CB3-B5B0-4084B5113267

P1433

Gastroenterology & hepatology

P1476

Controversies in the Diagnosis and Management of NAFLD and NASH.

@en

P2093

Brent Tetri

http://www.w3.org/2001/XMLSchema#string

Kris Kowdley

http://www.w3.org/2001/XMLSchema#string

Mary E Rinella

http://www.w3.org/2001/XMLSchema#string

Michael Charlton

http://www.w3.org/2001/XMLSchema#string

Rohit Loomba

http://www.w3.org/2001/XMLSchema#string

Stephen A Harrison

http://www.w3.org/2001/XMLSchema#string

Stephen H Caldwell

http://www.w3.org/2001/XMLSchema#string

P2860

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

From NAFLD in clinical practice to answers from guidelines

Alcohol consumption and mortality among middle-aged and elderly U.S. adults

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

P304

219-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24976805

http://www.w3.org/2001/XMLSchema#string

P932

4073533

http://www.w3.org/2001/XMLSchema#string